Gretchen Henkel | Issue: October 2012 |
With sadness we honor the passing of Morris Reichlin, MD. Dr. “Moe” Reichlin enjoyed a distinguished clinical, investigative, rheumatology career that spanned more than five decades. Moe was inquisitive, persistent, humble and inspiring. His achievements were many and diverse. Moe Reichlin received his BA and MD degrees from Washington University in St. Louis, where he…
During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…
New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention
SAN FRANCISCO—Two hundred years ago, physicians knew nothing about what caused various forms of arthritis. Today, we have more clues about what may trigger rheumatic diseases, but still can’t pinpoint the culprits that set scores of inflammatory conditions in motion. Researchers discussed some of the background and recent findings that point to what immunologists call…